NCT02843815View on ClinicalTrials.gov

Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 1, 2016

Primary Completion Date

July 1, 2017

Study Completion Date

July 1, 2019

Conditions
Non-small Cell Lung Cancer Metastatic
Interventions
DEVICE

Cryosurgery

Argon-helium cryosurgical system (percutaneous ablation under CT or ultrasound guidance)

BIOLOGICAL

NK Immunotherapy

Natural killer cell (each treatment: about 10 billion cells transfusion in 3 times, i.v.)

Trial Locations (1)

510665

Cancer Institute in Fuda cancer hospital, Guangzhou

All Listed Sponsors
collaborator

Shenzhen Hank Bioengineering Institute

OTHER

lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT02843815 - Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter